Today at a glance:
- Neuralink's upcoming trials will target vision restoration, merging AI technology with healthcare.
- CRISPR technology is paving the way for insulin-producing cells, offering new hope for diabetes treatment.
- Tesla is expanding its business model by selling supercharger stations directly to companies, enhancing EV accessibility.
- A surge of competition in the stablecoin market highlights the growing demand for efficient digital assets.